Company intelligence / Profile preview

Endoca

Europe

Ownership: Private
Development stage: Other

Overview

Endoca is a European-based company focused on producing high-quality, organic CBD products from hemp, emphasizing purity, sustainability, and transparency. Its products are not pharmaceuticals but nutraceuticals and wellness products, widely used for general health, anxiety, inflammation, and pain. Endoca is recognized for its rigorous quality control, GMP certification, and commitment to environmental sustainability. Clinical trials specific to drug indications are not a focus; instead, the company leverages the broad therapeutic potential of cannabinoids, particularly cannabidiol (CBD), as suggested by early research and anecdotal evidence.

Therapeutic areas: OtherNeurologyImmunologyPsychiatry
Modalities: Natural extractSmall moleculeCannabinoid-based oral productTopical productSupplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Endoca.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoca.

Explore the full profile